Safeguard Scientifics, Inc. (NYSE:SFE) announced that it has increased 2013 aggregate partner company revenue guidance to a range of $285 million to $295 million, up from its initial revenue guidance of $250 million to $270 million. This represents an increase of 44% to 49% as compared to $197.3 million in 2012. Results for Safeguard partner companies are reported on a one-quarter lag basis.
Safeguard also announced the final agenda and webcast information for Investor Day 2013. The event will be held at the New York Stock Exchange tomorrow, October 8, 2013 from 8:00 a.m. – 11:45 a.m. EDT.
RSVP: There is still time to RSVP. Please go to www.safeguard.com/InvestorDay2013 or email us at IR(at)safeguard(dot)com. PLEASE NOTE THAT DUE TO SECURITY RESTRICTIONS AT THE NEW YORK STOCK EXCHANGE, PRE-REGISTRATION IS REQUIRED.
|8:00 a.m.||Registration and Breakfast|
|8:30 a.m.||Opening Remarks|
|Stephen T. Zarrilli – Safeguard’s President and CEO|
|8:45 a.m.||Specialty Pharmaceuticals|
|AdvantEdge Healthcare Solutions, Inc.|
|Crescendo Bioscience, Inc.|
|Good Start Genetics, Inc.|
|Sotera Wireless, Inc.|
|11:05 a.m.||Digital Media|
|11:45 a.m.||Closing Remarks followed by Luncheon with Informal Conversation|
|Please call / login at least 15 minutes prior to register.|
|Call-in Number: 877-317-6789|
|Replay Number: 877-344-7529|
|Replay Access Code: 10034866|
|Replay available through November 8, 2013 at 9:00am EST|
About Safeguard ScientificsFounded in 1953 and based in the Greater Philadelphia area, Safeguard Scientifics, Inc. (NYSE:SFE) is celebrating 60 years of building market leaders and fostering innovation and entrepreneurship. Today, Safeguard provides growth capital and operational support to healthcare and technology companies in medtech, healthtech, specialty pharmaceuticals, financial technology, digital media, and Enterprise 3.0. For more information, please visit our website at www.safeguard.com. Safeguard Press Resources Blog: blog.safeguard.comTwitter: @SafeguardStockTwits: SFELinkedIn: Safeguard ScientificsYouTube: SafeguardSFESlideShare: SafeguardScientifics Forward-looking Statements Except for the historical information contained herein, statements in this release may constitute “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995. Forward-looking statements are subject to risks and uncertainties that could cause actual results to differ materially. These risks and uncertainties include, among others, the Company’s ability to make good decisions about the deployment of capital, the fact that our partner companies may vary from period to period, the Company’s substantial capital requirements and the absence of liquidity from our partner company holdings, the Company’s inability to obtain maximum value for our partner company holdings, market valuations in sectors in which our partner companies operate, the Company’s inability to control our partner companies, the need to manage assets to avoid registration under the Investment Company Act of 1940, risks associated with our partner companies, and other uncertainties described in the Company’s filings with the Securities and Exchange Commission. Many of these factors are beyond the Company’s ability to predict or control. As a result, past financial performance should not be relied on as an indication of future performance. The Company does not assume any obligation to update any forward-looking statements or other information in this press release.
Select the service that is right for you!COMPARE ALL SERVICES
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
- Weekly roundups
Access the tool that DOMINATES the Russell 2000 and the S&P 500.
- Buy, hold, or sell recommendations for over 4,300 stocks
- Unlimited research reports on your favorite stocks
- A custom stock screener
- Upgrade/downgrade alerts
- Diversified model portfolio of dividend stocks
- Alerts when market news affect the portfolio
- Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
- Real Money + Doug Kass Plus 15 more Wall Street Pros
- Intraday commentary & news
- Ultra-actionable trading ideas
- 100+ monthly options trading ideas
- Actionable options commentary & news
- Real-time trading community
- Options TV